Immunization and Vaccination are crucial components of public health strategies aimed at preventing infectious diseases and protecting individuals and communities from their harmful effects. While the terms "immunization" and "vaccination" are often used interchangeably, they refer to distinct but related concepts within the realm of disease prevention.
Vaccination refers specifically to the process of administering a vaccine, a biological preparation that stimulates the immune system to recognize and mount a protective response against a particular pathogen, such as a virus or bacterium. Vaccines can contain live, weakened, or inactivated forms of the pathogen, as well as specific components or antigens derived from the pathogen. Immunization, on the other hand, refers to the overall process of inducing immunity to a disease through vaccination or by other means, such as natural infection. Immunization can lead to the development of long-lasting immunity, providing protection against future encounters with the pathogen.
The goal of immunization and vaccination programs is to achieve herd immunity, also known as community immunity, where a significant proportion of the population is immune to a disease, thereby reducing the overall transmission and prevalence of the disease within the community. This not only protects vaccinated individuals but also provides indirect protection to those who are not vaccinated, such as infants, elderly individuals, and those with compromised immune systems. Immunization and vaccination have been instrumental in controlling and eradicating many infectious diseases that were once widespread and deadly. Diseases such as smallpox, polio, and measles have been effectively controlled or eliminated in many parts of the world through vaccination campaigns and routine immunization programs.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe